Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¹æ±¤¾Ï¿¡¼­ ±ÙÄ¡Àû ¹æ±¤ÀûÃâ¼ú ÈÄ ¿¹ÈÄÀÎÀÚ¿¡ µû¸¥ »ýÁ¸À²ºÐ¼® Retrospective Survival Analysis according to Prognostic Factors after Radical Cystectomy in Bladder Cancer

´ëÇѺñ´¢±â°úÇÐȸÁö 1999³â 40±Ç 3È£ p.316 ~ 321
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÇöº¸/Hyun Bo Lee ÀÌÁö¿­/±è¼¼¿õ/Á¶¿ëÇö/À±¹®¼ö/Ji Youl Lee/Sae Woong Kim/Youg Hyun Cho/Moon Soo Yoon

Abstract

¼­·Ð
¹æ±¤¾ÏÀ¸·Î Áø´ÜµÈ ȯÀÚÀÇ 25%´Â ħÀ±¼º ¹æ±¤¾ÏÀ¸·Î Áø´ÜµÇ°í, ħÀ±¼º ¹æ±¤¾ÏÀ¸·Î Áø´Ü
µÈ ȯÀÚÀÇ 50%´Â ¿ø°ÝÀüÀÌ°¡ ÀÖÀ¸¸ç ¿ø°ÝÀüÀÌ°¡ Àִ ȯÀÚÀÇ ´ëºÎºÐÀº 2³â À̳»¿¡ »ç¸ÁÇÏ
´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. ħÀ±¼º ¹æ±¤¾Ï¿¡¼­ ±ÙÄ¡Àû ¹æ±¤ÀûÃâ¼ú ¹× °ñ¹Ý°­ ÀÓÆÄÀýÀýÁ¦¼úÀº ´Ü
ÀÏ Ä¡·á·Î´Â °¡Àå ÁÁÀº Ä¡·á¹ýÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ±×¿Ü¿¡µµ ¹æ»ç¼±Ä¡·á³ª Ç×¾ÏÈ­Çпä¹ý µî
¿Í ´Ù¾çÇÑ ¹æ¹ýÀ» ÅëÇÏ¿© Ä¡·áÇÏ¿© ħÀ±¼º ¹æ±¤¾ÏȯÀÚÀÇ ¼úÈÄ »ýÁ¸À²À» ³ôÀÌ·Á°í ³ë·ÂÇÏ°í
ÀÖÀ¸³ª ¾ÆÁ÷±îÁö ¼ö¼ú¹æ¹ýº¸´Ù ´õ È¿°úÀûÀÎ Ä¡·á¹ýÀº ¾ø´Â ½ÇÁ¤ÀÌ´Ù.
ÀÌ¿¡ ÀúÀÚµéÀº ±ÙÄ¡Àû ¹æ±¤ÀûÃâ¼ú ¹× °ñ¹Ý°­ ÀÓÆÄÀý¸¦½ÃÇàÇÑ Ä§À±¼º ¹æ±¤¾Ï ȯÀÚ¿¡¼­ »ý
Á¸À²¿¡ Áß¿äÇÑ ¿µÇâÀ» ¹ÌÄ¡´Â ¿¹ÈÄÀÎÀÚ¸¦ ¾Ë±â À§ÇÏ¿© ¿¬·É, ¼ºº°, Á¾¾çÀÇ º´±â ¹× ºÐÈ­µµ,
º´¸®Á¶Á÷ ¼Ò°ß»ó Á¾¾ç¼¼Æ÷ÀÇ ÀÓÆļ± ¹× Ç÷°ü ħÀ±¿©ºÎ, ¼ö¼ú½Ã ÀÓÆÄÀý ħ¹ü¿©ºÎ, ÀüÀÌ¿©ºÎ¸¦
ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿© »ýÁ¸À²°úÀÇ °ü°è¸¦ ¾Ë¾Æº¸°í À̵éÁß¿¡¼­ ¿¹ÈÄÀÎÀÚ¸¦ ºÐ¼®ÇÏ¿© ¿¹ÈÄÀÎ
ÀÚ µû¸¥ »ýÁ¸À²À» ºñ±³ÇÏ°íÀÚ ÇÏ¿´´Ù.

Purpose: Radical cystectomy with pelvic lymphadenectomy is effective therapeutic
modality in the management of invasive bladder cancer. We reviewed our experience in
order to determine the prognostic factors on survival after radical cystectomy with
pelvic lymphadenectomy.
Materials and Methods: An analysis was performed of 113 patients with bladder
cancer who underwent radical cystectomy with pelvic lymphadenectomy from 1988 to
1997. Ages ranged from 46 to 78-year-old, average age was 61.4¡¾9.8 years old. The
survival rate according to each factor was calculated by Kaplan-Meier method. Statistics
was determined by the log-rank test.
Results: 3-year survival rate was 80% in the male patients and 66% in the female
patients. Comparing between organ confined(¡ÂpT3a) and non-organ confined disease(¡Ã
pT3b), 3-year survival rate was 86% for organ confined disease and 34% for non-organ
confined disease. 3-year survival rate of the patients with grade ¥° cancer was 96%,
grade ¥± cancer 86% and grade ¥² cancer 66%. According to microscopic vascular
invasion of the bladder tumor, 3-year survival rate in vascular invasion was 66% and
80% in non-vascular invasion. According to microscopic lymphatic invasion of the
bladder tumor, 3-year survival rate was 62% in lymphatic invasion and 88% in
non-lymphatic invasion. According to the states of lymph node invasion, 3-year survival
rate in the NO was 84%, in N1 74% and in N2¡Â 0%. According to the metastasis
3-year survival rate in the absence of metastasis was 90% in nodal invasion 32% and
in visceral organ metastasis 26%.
There were statistical significant differences in sex, pathologic stage grade lymph
node invasion and distant metastasis(p<0.05).
Conclusions: From this study, we think the prognostic factors affecting survival after
radical cystectomy with pelvic lymphadenectomy may be sex, pathologic stage, grade,
lymph node invasion and distant metastasis. Therefore careful and more frequent
followup is needed in patients with poor prognostic factor.

Å°¿öµå

Bladder cancer; Radical cystectomy; Survival;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS